2019年加拿大的处方药支出：聚焦公共药品计划

Prescribed Drug Spending in Canada, 2019: A Focus on Public Drug Programs.

作者信息

Lee Kathy, Jani Trupti, Cheng Roger, Hunt Jordan

机构信息

A program lead in the Pharmaceuticals Department at the CIHI in Ottawa, Ontario. She leads and coordinates the analysis and writing of pharmaceutical-related reports at CIHI. Kathy can be reached at

A senior analyst in the Pharmaceuticals Department at the CIHI in Ottawa, Ontario. She assisted with the analysis and writing of the Drug Spending in Canada reports at CIHI. Trupti can be reached at

出版信息

Healthc Q. 2020 Apr;23(1):10-12. doi: 10.12927/hcq.2020.26145.

DOI:10.12927/hcq.2020.26145

PMID:32249733

Abstract

Public drug program spending accounts for 43.1% of prescribed drug spending in Canada. This report provides an in-depth look at public drug program spending in Canada, using the Canadian Institute for Health Information's (CIHI) National Prescription Drug Utilization Information System. Public drug program spending does not include spending on drugs dispensed in hospitals or on those funded through cancer agencies and other special programs.

摘要

公共药品项目支出占加拿大处方药支出的43.1%。本报告利用加拿大卫生信息研究所（CIHI）的全国处方药利用信息系统，深入探讨了加拿大公共药品项目的支出情况。公共药品项目支出不包括医院配药支出或通过癌症机构及其他特殊项目资助的药品支出。